Ticker Details
Baxter International Inc. Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$8.93B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.49 | 0.93%
Avg Daily Range (30 D):	$0.30 | 1.74%
Avg Daily Range (90 D):	$0.32 | 1.66%

Institutional Daily Volume
Avg Daily Volume:	3.44M
Avg Daily Volume (30 D):	7.31M
Avg Daily Volume (90 D):	7.51M

Trade Size
Avg Trade Size (Sh.):	147
Avg Trade Size (Sh.) (30 D):	117
Avg Trade Size (Sh.) (90 D):	121

Institutional Trades
Total Institutional Trades:	63,592
Avg Institutional Trade:	$3.82M
Avg Institutional Trade (30 D):	$5.54M
Avg Institutional Trade (90 D):	$4.43M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	11

Market Closing Trades
Avg Closing Trade:	$20.34M
Avg Closing Trade (30 D):	$36.33M
Avg Closing Trade (90 D):	$27.35M
Avg Closing Volume:	396.03K

News

Apr 9, 2026 @ 8:57 AM Robotic Pharmacy Prescription Market Research and ... Source: Researchandmarkets.Com

Mar 25, 2026 @ 12:01 PM EXCLUSIVE: Petrochemical Crunch From Iran War Isn'... Source: Eva Mathew

Mar 24, 2026 @ 5:24 PM Manufacturing Disruption Hits Baxter Cancer Drug S... Source: Vandana Singh

Mar 17, 2026 @ 9:26 AM The ’Battleship’ Plan for 8.2%+ Divi... Source: Brett Owens

Mar 13, 2026 @ 8:30 AM Intravenous (IV) Solutions Market Size to Reach US... Source: Sns Insider

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.87	$-2.2	$-1.87
Diluted EPS	$-1.87	$-2.2	$-1.87
Revenue	$11.24B	$2.97B	$11.24B
Gross Profit	$3.38B	$577M	$3.38B
Net Income / Loss	$-957M	$-1128M	$-957M
Operating Income / Loss	$-308M	$-729M	$-308M
Cost of Revenue	$7.87B	$2.4B	$7.87B
Net Cash Flow	$-530M	$156M	$-530M
PE Ratio

Splits
May 31, 2001	2:1